LGC acquires LINK and strengthens its oligo reagents offering
News - LINK Technologies is a premier supplier of speciality reagents for oligonucleotide synthesis
19 July 2017
LGC acquires Axolabs and invests in GMP manufacturing capacity for therapeutic nucleic acids
News - Moves strengthen existing analytical and bioanalytical drug development service offering
03 April 2017
Innovate UK Awards Grant to MiNA Therapeutics and LGC LINK
News - Funding to develop liver targeted gene activation therapies
02 November 2017